{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:43:44Z","timestamp":1788270224275,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jjcc.2025.12.006","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T02:32:00Z","timestamp":1765593120000},"page":"429-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cardio-ankle vascular index as a screening tool for coronary artery disease in patients with metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1016","volume":"87","author":[{"given":"Mitsutaka","family":"Nakashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Osawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Yuasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2025.12.006_bb0005","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jjcc.2025.12.006_bb0010","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jjcc.2025.12.006_bb0015","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jjcc.2022.10.002","article-title":"Association of the severity of vascular damage with discordance between the fractional flow reserve and non-hyperemic pressure ratios","volume":"81","author":"Sasaki","year":"2023","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2025.12.006_bb0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12933-024-02268-1","article-title":"Prognostic value of metabolic dysfunction-associated steatotic liver disease over coronary computed tomography angiography findings: comparison with no-alcoholic fatty liver disease","volume":"23","author":"Nishihara","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jjcc.2025.12.006_bb0025","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.124.070535","article-title":"Cardiovascular-liver-metabolic health: Recommendations in screening, diagnosis, and management of metabolic dysfunction-associated steatotic liver disease in cardiovascular disease via modified Delphi approach","volume":"151","author":"Chew","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2025.12.006_bb0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5551\/jat.13.101","article-title":"A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI)","volume":"13","author":"Shirai","year":"2006","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jjcc.2025.12.006_bb0035","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jjcc.2021.07.011","article-title":"Arterial stiffness in health and disease: the role of cardio-ankle vascular index","volume":"78","author":"Miyoshi","year":"2021","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2025.12.006_bb0040","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1161\/HYPERTENSIONAHA.118.11554","article-title":"Physiological diagnostic criteria for vascular failure","volume":"72","author":"Tanaka","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jjcc.2025.12.006_bb0045","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020103","article-title":"Predictive value of the cardio-ankle vascular index for cardiovascular events in patients at cardiovascular risk","volume":"10","author":"Miyoshi","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jjcc.2025.12.006_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jjcc.2025.12.006_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.101685","article-title":"Prognostic value of pericoronary fat attenuation index on computed tomography for hospitalization for heart failure","volume":"4","author":"Nakashima","year":"2025","journal-title":"JACC Adv"},{"key":"10.1016\/j.jjcc.2025.12.006_bb0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jcct.2020.11.002","article-title":"Society of Cardiovascular Computed Tomography\/North American Society of Cardiovascular Imaging - expert consensus document on coronary CT imaging of atherosclerotic plaque","volume":"15","author":"Shaw","year":"2021","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/j.jjcc.2025.12.006_bb0065","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.jcmg.2020.01.022","article-title":"Prognostic value of coronary computed tomographic angiography in patients with nonalcoholic fatty liver disease","volume":"13","author":"Ichikawa","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.jjcc.2025.12.006_bb0070","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/eurjpc\/zwab120","article-title":"Incremental prognostic value of non-alcoholic fatty liver disease over coronary computed tomography angiography findings in patients with suspected coronary artery disease","volume":"28","author":"Ichikawa","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jjcc.2025.12.006_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101019","article-title":"Prognostic value of cardio-ankle vascular index for cardiovascular and kidney outcomes: systematic review and meta-analysis","volume":"3","author":"Tavolinejad","year":"2024","journal-title":"JACC Adv"},{"key":"10.1016\/j.jjcc.2025.12.006_bb0080","first-page":"368","article-title":"Cardio-ankle vascular index as an arterial stiffness marker improves the prediction of cardiovascular events in patients without cardiovascular diseases","volume":"9","author":"Okamoto","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.jjcc.2025.12.006_bb0085","doi-asserted-by":"crossref","first-page":"539","DOI":"10.5551\/jat.281","article-title":"Effects of pitavastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardio-ankle vascular index in type 2 diabetic patients","volume":"16","author":"Miyashita","year":"2009","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jjcc.2025.12.006_bb0090","doi-asserted-by":"crossref","first-page":"517","DOI":"10.5551\/jat.3707","article-title":"Changes in cardio-ankle vascular index in smoking cessation","volume":"17","author":"Noike","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jjcc.2025.12.006_bb0095","doi-asserted-by":"crossref","first-page":"568","DOI":"10.5551\/jat.1628","article-title":"Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy","volume":"16","author":"Sasaki","year":"2009","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jjcc.2025.12.006_bb0100","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.orcp.2011.08.154","article-title":"Effects of body weight reduction on cardio-ankle vascular index (CAVI)","volume":"7","author":"Nagayama","year":"2013","journal-title":"Obes Res Clin Pract"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508725003053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508725003053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:02:53Z","timestamp":1777633373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508725003053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0914508725003053"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2025.12.006","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardio-ankle vascular index as a screening tool for coronary artery disease in patients with metabolic dysfunction-associated steatotic liver disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2025.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of Japanese College of Cardiology.","name":"copyright","label":"Copyright"}]}}